Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet’s disease

摘要

ObjectiveTo assess the long-term efficacy and safety of infliximab (IFX) treatment for refractory uveitis associated with Behçet’s disease (BD) and to identify predictors of long-term IFX therapy outcomes.